These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27636927)

  • 1. [Long-term infliximab therapy for ulcerative colitis in real clinical practice].
    Knyazev OV; Parfenov AI; Kagramanova AV; Ruchkina IN; Shcherbakov PL; Shakhpazyan NK; Noskova KK; Ivkina TI; Khomeriki SG
    Ter Arkh; 2016; 88(8):46-52. PubMed ID: 27636927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis.
    Church PC; Ho S; Sharma A; Tomalty D; Frost K; Muise A; Walters TD; Griffiths AM
    J Crohns Colitis; 2019 Aug; 13(8):982-989. PubMed ID: 30715240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial.
    Choy MC; Li Wai Suen CFD; Con D; Boyd K; Pena R; Burrell K; Rosella O; Proud D; Brouwer R; Gorelik A; Liew D; Connell WR; Wright EK; Taylor KM; Pudipeddi A; Sawers M; Christensen B; Ng W; Begun J; Radford-Smith G; Garg M; Martin N; van Langenberg DR; Ding NS; Beswick L; Leong RW; Sparrow MP; De Cruz P
    Lancet Gastroenterol Hepatol; 2024 Nov; 9(11):981-996. PubMed ID: 39236736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.
    Johnsen KM; Goll R; Hansen V; Olsen T; Rismo R; Heitmann R; Gundersen MD; Kvamme JM; Paulssen EJ; Kileng H; Johnsen K; Florholmen J
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):98-104. PubMed ID: 27749779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitis.
    Hussey M; Mc Garrigle R; Kennedy U; Holleran G; Kevans D; Ryan B; Breslin N; Mahmud N; McNamara D
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):217-21. PubMed ID: 26587866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
    Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
    World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis.
    Fernández-Salazar L; Barrio J; Muñoz F; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; González-Redondo G; Fernández N; Santos F; Sánchez-Ocaña R; Joao D;
    Rev Esp Enferm Dig; 2015 Sep; 107(9):527-33. PubMed ID: 26334458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.
    Murthy SK; Greenberg GR; Croitoru K; Nguyen GC; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2015 Sep; 21(9):2090-6. PubMed ID: 26099066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience.
    Filippi J; Laharie D; Michiels C; Flamand M; Bouguen G; Nancey S; Presles E; Paul S; Schneider S; Hébuterne X; Roblin X
    J Crohns Colitis; 2015 Mar; 9(3):252-8. PubMed ID: 25588386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis.
    Kobayashi T; Suzuki Y; Motoya S; Hirai F; Ogata H; Ito H; Sato N; Ozaki K; Watanabe M; Hibi T
    J Gastroenterol; 2016 Mar; 51(3):241-51. PubMed ID: 26162647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine.
    Cortes X; Borrás-Blasco J; Fernendez S; Moreno M; Rodríguez J; Molés JR; Casterá E
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):125-8. PubMed ID: 26754306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
    Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
    Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis.
    Gibson DJ; Heetun ZS; Redmond CE; Nanda KS; Keegan D; Byrne K; Mulcahy HE; Cullen G; Doherty GA
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):330-335.e1. PubMed ID: 25086187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.
    Cesarini M; Katsanos K; Papamichael K; Ellul P; Lakatos PL; Caprioli F; Kopylov U; Tsianos E; Mantzaris GJ; Ben-Horin S; Danese S; Fiorino G
    Dig Liver Dis; 2014 Feb; 46(2):135-9. PubMed ID: 24246151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study.
    Iwańczak BM; Kierkuś J; Ryżko J; Szczepanik M; Więcek S; Czaja-Bulsa G; Kacperska M; Korczowski B; Maślana J; Iwańczak F
    Adv Clin Exp Med; 2017; 26(1):57-61. PubMed ID: 28397433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term efficacy of azathioprine in steroid-dependent ulcerative colitis.
    Park SK; Yang SK; Ye BD; Kim KJ; Yang DH; Jung KW; Park SH; Kim JW; Byeon JS; Myung SJ; Kim JH
    Scand J Gastroenterol; 2013 Dec; 48(12):1386-93. PubMed ID: 24164382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.